Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Diseases
92%
Infection
71%
Malaria
65%
Returning Traveler
44%
Schistosomiasis
35%
Rapid Diagnostic Test
26%
Dengue Fever
26%
Human immunodeficiency virus
25%
Diagnostic Accuracy
22%
Malaria Falciparum
21%
Plasmodium
21%
Retrospective Study
20%
Monkeypox
20%
Parasite (Microbiology)
19%
Antigen
19%
Cross Sectional Study
19%
Pathogen
19%
Morbidity
17%
Health Care Personnel
16%
Neurocysticercosis
15%
Diagnosis
15%
Prevalence
15%
Clinical Management
14%
Neglected Tropical Diseases
14%
Retrospective Cohort Study
14%
Low and Middle Income Countries
13%
Cohort Effect
13%
Weil's Disease
13%
Tropical Disease
13%
Antimicrobial Agent
12%
Randomized Controlled Trial
12%
Schistosoma
12%
Taenia solium
11%
African Trypanosomiasis
11%
Prospective Cohort Study
11%
Schistosoma haematobium
10%
Coxiella burnetii
10%
Tuberculosis
10%
Case Definition
10%
Artesunate
10%
Artemisinin
10%
Chikungunya
10%
Post-Exposure Prophylaxis
10%
Antibody Response
10%
Bartonella
9%
Clinical Feature
9%
Taeniasis
9%
Travel Related Disease
9%
Praziquantel
9%
Systematic Review
9%
Immunology and Microbiology
Infection
100%
Infectious Disease
100%
Malaria
51%
Schistosomiasis
38%
Viral Disease
29%
Plasmodium
25%
Parasite
25%
Plasmodium falciparum
24%
Antigen
20%
Human immunodeficiency virus
16%
Infectious Agent
14%
Taenia solium
14%
COVID-19
14%
Salmonella
12%
Schistosoma
12%
Immunogenicity
11%
Schistosoma haematobium
11%
Dengue Fever
11%
Chikungunya virus
11%
Zika virus
10%
Coxiella burnetii
10%
Normal Human
10%
Viral Shedding
10%
Booster Dose
10%
Serology
9%
Praziquantel
9%
Prevalence
9%
Cysticercosis
9%
Rabies
9%
Monkeypox Virus
9%
Parasitology
9%
Antibiotic Sensitivity
9%
Bartonella
9%
C-Reactive Protein
9%
Multiplex Polymerase Chain Reaction
9%
Plasmodium malariae
8%
Bacterium
8%
Cladistics
6%
Human Immunodeficiency Virus Infection
6%
Erythrocyte
6%
Cutaneous Leishmaniasis
6%
Campylobacter
6%
Leukocyte Count
6%
Real-Time Polymerase Chain Reaction
5%
T Cell
5%
Escherichia coli
5%
Cohort Effect
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Lactic Acid
5%
Real Time Polymerase Chain Reaction
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malaria
46%
Diseases
28%
Antimicrobial Agent
16%
Infection
14%
Neurocysticercosis
14%
Schistosomiasis
14%
Malaria Falciparum
14%
Praziquantel
12%
Taenia solium
11%
Parasite
11%
Antimalarial Agent
11%
Artesunate
10%
Taeniasis
9%
Hydroxychloroquine
9%
Artemisinin
9%
Randomized Controlled Trial
9%
Dengue
9%
Mefloquine
9%
Retrospective Study
9%
Plasmodium
8%
Epidemiology
7%
Rabies Immunoglobulin
5%
Cysticercosis
5%
Elimination
5%
Leishmaniasis
5%
HIV
5%
Combination Therapy
5%
Salmonella
5%
Ciprofloxacin
5%
Vaccination
5%
Off-Label Use
5%
Prospective Cohort Study
5%